Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-09 2023-04-06 186575
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-03-16 2023-04-06 187238
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-14 2024-02-02 189647
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-29 190874
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-06-09 191880
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-06 2023-05-12 191898
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-07-21 192800
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-19 2023-06-23 192818
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2023-05-26 2023-07-21 193218
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-02 2023-08-12 193614
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-08-04 195091
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-23 196297
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-04 196300
APO-OXYCODONE CR 80.0MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-12 196312
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-04 199527
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-07-27 2024-03-15 200177
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-13 2023-10-15 201719
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-11-06 202824

Showing 2921 to 2940 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-CICLESONIDE 50MCG SPRAY, METERED DOSE Discontinued 2018-12-20 2018-12-21 70250
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-NITRAZEPAM 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-NITRAZEPAM 10MG TABLET Discontinued 2017-03-13 2018-12-07 1117

Showing 101 to 120 of 356